Lincoln Pharmaceuticals Limited Recommended a dividend of INR 1.50/- (i.e. 15% per share) per equity share of face value of INR 10/- for the year ended March 31, 2023, for approval of the members at the ensuring annual general meeting (AGM) of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
597.1 INR | +0.13% | -0.39% | -1.98% |
1st Jan change | Capi. | |
---|---|---|
-1.98% | 143M | |
+26.08% | 681B | |
+21.85% | 556B | |
-5.21% | 361B | |
+17.32% | 325B | |
+4.87% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-4.17% | 157B |
- Stock Market
- Equities
- LINCOLN Stock
- News Lincoln Pharmaceuticals Limited
- Lincoln Pharmaceuticals Limited Recommends A Dividend for the Year Ended March 31, 2023